<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02160236</url>
  </required_header>
  <id_info>
    <org_study_id>2013/469</org_study_id>
    <nct_id>NCT02160236</nct_id>
  </id_info>
  <brief_title>Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam</brief_title>
  <official_title>Comparison of Postoperative Analgesic Efficacy of Intravenous Dexketoprofen Trometamol With Tenoxicam in Lumbar Disc Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TC Erciyes University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TC Erciyes University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study the investigators aimed to compare of postoperative analgesic effects of
      intravenous dexketoprofen trometamol and tenoxicam in lumbar disc surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lumbar disc surgery is associated with moderate to severe back and radicular pain
      postoperatively which has unfavorable effects on patients recovery and procedures outcome.
      Dexketoprofen has been reported to be one of the NSAİDs that can provide good results when
      compared with narcotics in many painful conditions and especially in the treatment of the
      moderate to severe postoperative pain that may develop after lumbal disc surgery. Tenoxicam
      is a thienothiazine derivative of the oxicam class of NSAİDs. There are some studies in which
      NSAİDs have been used to together with opioids for postoperative analgesia showing that they
      decrease opioid consumption and side effects
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>November 2014</start_date>
  <completion_date type="Anticipated">February 2015</completion_date>
  <primary_completion_date type="Anticipated">February 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>analgesic consumption</measure>
    <time_frame>postoperative 1 day</time_frame>
    <description>morphine consumption (patient control analgesia procedure) was recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual analog scale</measure>
    <time_frame>postoperative 1 day</time_frame>
    <description>visual analog scale on rest and movement was recorded</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Postoperative Pain</condition>
  <arm_group>
    <arm_group_label>dexketoprofen trometamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>before end of the surgery via intravenous administration 50 mg dexketoprofen trometamol in 0.9 % NaCl 100 cc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tenoxicam</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>before the end of the surgery via administration intravenous 20 mg tenoxicam in 0.9% NaCl in 100 cc</description>
  </arm_group>
  <arm_group>
    <arm_group_label>serum physiologic</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>before end of the surgery via administration intravenous 0.9 % NaCl 100 cc</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexketoprofen trometamol</intervention_name>
    <description>before end of the surgery via intravenous administration 50 mg dexketoprofen trometamol in 0.9 % NaCl 100 cc</description>
    <arm_group_label>dexketoprofen trometamol</arm_group_label>
    <other_name>arveles</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tenoxicam</intervention_name>
    <description>before the end of the surgery via administration intravenous 20 mg tenoxicam in 0.9% NaCl in 100 cc</description>
    <arm_group_label>tenoxicam</arm_group_label>
    <other_name>oksamen</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>serum physiologic</intervention_name>
    <description>before end of the surgery via administration intravenous 0.9 % NaCl 100 cc</description>
    <arm_group_label>serum physiologic</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA 1-2

          -  between 18-65 age

          -  elective lumbar disc surgery

        Exclusion Criteria:

          -  history of gastrointestinal bleeding

          -  peptic ulcer disease

          -  bleeding disorders

          -  history of allergic reactions to NSAİDs

          -  chronic pain syndrome
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>nazife küçük, resident</last_name>
    <role>Principal Investigator</role>
    <affiliation>TC Erciyes University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nazife Küçük, resident</last_name>
    <phone>+905072317446</phone>
    <email>nzfkucuk@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Halit Madenoğlu, prof</last_name>
    <phone>+903522076666</phone>
    <phone_ext>24032</phone_ext>
    <email>halitm@erciyes.edu.tr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Erciyes Universty Hospital</name>
      <address>
        <city>Kayseri</city>
        <zip>38039</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>nazife küçük, resident</last_name>
      <phone>+905072317446</phone>
      <email>nzfkucuk@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 8, 2014</study_first_submitted>
  <study_first_submitted_qc>June 9, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2014</study_first_posted>
  <last_update_submitted>November 7, 2014</last_update_submitted>
  <last_update_submitted_qc>November 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>TC Erciyes University</investigator_affiliation>
    <investigator_full_name>Nazife Küçük</investigator_full_name>
    <investigator_title>resident</investigator_title>
  </responsible_party>
  <keyword>dexketoprofen trometamol</keyword>
  <keyword>tenoxicam</keyword>
  <keyword>postoperative pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics</mesh_term>
    <mesh_term>Dexketoprofen trometamol</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
    <mesh_term>Tenoxicam</mesh_term>
    <mesh_term>Piroxicam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

